Investor Relations

CHF Solutions is an early stage company focused on commercializing the Aquadex FlexFlow® system. Our objective is to improve the quality of life for patients with heart failure and related conditions, such as fluid overload. CHF Solutions is listed on the NASDAQ Capital Market.

Press Releases

CHF Solutions Adds Six Seasoned Sales Professionals to Sales Force
Posted on Aug 29, 2017
EDEN PRAIRIE, Minn., Aug. 29, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today it has added six seasoned sales professionals to its commercial sales organization to better serve its customer demand. The new sales representatives joined CHF Solutions from top tiered medica...

Read More

CHF Solutions to Exhibit at the ESC Congress 2017 in Barcelona, Spain, August 26-30, 2017
Posted on Aug 24, 2017
EDEN PRAIRIE, Minn., Aug. 24, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) announced today it will be exhibiting at the European Society of Cardiology, ESC Congress 2017 meeting in Barcelona, Spain, from August 26 through August 30, 2017 in the Emerging Technology Showcase Area at bo...

Read More

CHF Solutions, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Posted on Aug 23, 2017
EDEN PRAIRIE, Minn., Aug. 23, 2017 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), today announced that on August 17, 2017, the Compensation Committee of the Board of Directors approved eleven equity awards under CHF Solution's New-Hire Equity Incentive Plan, as material inducements to elev...

Read More

View all press releases »

Events & Presentations

6th Annual Intellisight Investor Conference
Posted on Aug 22, 2017 at 3:35 PM CT
CHF Solutions, Inc. Second Quarter 2017 Earnings
Posted on Aug 8, 2017 at 9:00 AM
CHF Solutions 2017 Annual Meeting of Stockholders
Posted on May 25, 2017
View all events & presentations »